1. Home
  2. NVCR vs ENVX Comparison

NVCR vs ENVX Comparison

Compare NVCR & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • ENVX
  • Stock Information
  • Founded
  • NVCR 2000
  • ENVX 2006
  • Country
  • NVCR Switzerland
  • ENVX United States
  • Employees
  • NVCR N/A
  • ENVX N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • ENVX Industrial Machinery/Components
  • Sector
  • NVCR Health Care
  • ENVX Miscellaneous
  • Exchange
  • NVCR Nasdaq
  • ENVX Nasdaq
  • Market Cap
  • NVCR 2.3B
  • ENVX 2.1B
  • IPO Year
  • NVCR 2015
  • ENVX N/A
  • Fundamental
  • Price
  • NVCR $17.82
  • ENVX $7.34
  • Analyst Decision
  • NVCR Strong Buy
  • ENVX Strong Buy
  • Analyst Count
  • NVCR 4
  • ENVX 11
  • Target Price
  • NVCR $37.50
  • ENVX $20.64
  • AVG Volume (30 Days)
  • NVCR 795.3K
  • ENVX 4.6M
  • Earning Date
  • NVCR 05-01-2025
  • ENVX 04-30-2025
  • Dividend Yield
  • NVCR N/A
  • ENVX N/A
  • EPS Growth
  • NVCR N/A
  • ENVX N/A
  • EPS
  • NVCR N/A
  • ENVX N/A
  • Revenue
  • NVCR $605,220,000.00
  • ENVX $23,074,000.00
  • Revenue This Year
  • NVCR $3.41
  • ENVX $53.25
  • Revenue Next Year
  • NVCR $9.24
  • ENVX $337.98
  • P/E Ratio
  • NVCR N/A
  • ENVX N/A
  • Revenue Growth
  • NVCR 18.82
  • ENVX 201.86
  • 52 Week Low
  • NVCR $11.70
  • ENVX $5.70
  • 52 Week High
  • NVCR $34.13
  • ENVX $18.68
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 33.96
  • ENVX 36.63
  • Support Level
  • NVCR $18.23
  • ENVX $7.73
  • Resistance Level
  • NVCR $19.06
  • ENVX $9.07
  • Average True Range (ATR)
  • NVCR 0.80
  • ENVX 0.51
  • MACD
  • NVCR 0.02
  • ENVX 0.05
  • Stochastic Oscillator
  • NVCR 5.57
  • ENVX 18.78

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About ENVX Enovix Corporation

Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.

Share on Social Networks: